drugset / Trial / NCT04131556
A Study Comparing the Pharmacokinetics and Palatability of Two Candidate Pediatric Powder-for-Oral-Suspension Formulations of Maribavir to the Current Maribavir Tablet Formulation Administered in Healthy Adult Participants
RandomizedCrossoverOpen-labelTreatment
Summary
The Purpose of this study is to assess the relative bioavailability, dose proportionality, the impact of food on the rate and extent of absorption, palatability of the selected pediatric formulation of maribavir and the safety and tolerability of two candidate pediatric formulations and the adult tablet formulation of maribavir in healthy participants.
Timeline
- Start
- 2019-10-25
- Primary completion
- 2020-01-06
- Completion
- 2020-01-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Maribavir | Small molecule | 50 mg | Oral |
| Subject | Maribavir | Small molecule | 100 mg | Oral |
| Subject | Maribavir | Small molecule | 200 mg | Oral |
Indications
No indication recorded.